WeVote
Log In

Bill

Bill

SB 332

Health Care Practitioner Transparency Act.

2025-2026 Session Introduced by Jim Burgin and 3 co-sponsors

Bill requires North Carolina health care practitioners to disclose financial ties to pharmaceutical companies and medical device manufacturers to promote transparency and address conflicts of interest.

Passed 1st Reading
0
WeVote Research Nonpartisan
Bill Summary · SB 332

Legislative bill overview

SB 332 requires health care practitioners in North Carolina to disclose financial interests, ownership stakes, and business relationships with pharmaceutical companies, medical device manufacturers, and other health care entities. The bill establishes transparency standards for practitioners and creates mechanisms for public access to this information.

Why is this important

Transparency in health care practitioner finances addresses potential conflicts of interest that could influence treatment recommendations or prescribing practices. This affects patient trust in medical recommendations and helps identify situations where financial incentives might influence clinical decisions. Similar federal transparency laws (like the Physician Payments Sunshine Law) have revealed substantial undisclosed relationships between practitioners and industry.

Potential points of contention

  • Implementation burden: Practitioners and health care organizations face compliance costs for tracking, reporting, and managing disclosures, potentially straining smaller practices and rural providers
  • Privacy concerns: Public disclosure of financial relationships could expose personal business information and may deter legitimate consulting or research partnerships
  • Definition scope: Ambiguity about what relationships trigger disclosure requirements (research funding vs. speaking fees vs. ownership stakes) could create compliance confusion and legal challenges

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.